Guanfacine

Overview

Guanfacine is an oral alpha-2A adrenergic agonist medication primarily used to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure (hypertension)¹². Sold under brand names like Tenex (immediate-release) and Intuniv (extended-release), it helps manage ADHD symptoms such as inattention, hyperactivity, and impulsivity in children and adolescents aged 6-17, often as part of a comprehensive treatment plan including therapy²⁵⁶. For hypertension, it reduces blood pressure by relaxing blood vessels and controlling nerve impulses². Originally developed for hypertension, its use expanded to ADHD due to effects on prefrontal cortex function, improving attention and impulse control¹. It may also aid sleep issues in PTSD and tics¹⁴. Guanfacine is prescription-only and works by decreasing sympathetic nervous system activity¹.

Forms and Variations

Guanfacine is available in two main forms: immediate-release tablets (Tenex) and extended-release tablets (Intuniv)¹²⁴. Extended-release formulations are preferred for ADHD treatment in children and teens as they provide steady drug levels throughout the day, improving compliance and reducing peak-related side effects like sedation⁵⁷. Immediate-release is typically used for hypertension and requires multiple daily doses². Tablets come in strengths like 1 mg, 2 mg, 3 mg, and 4 mg for extended-release²⁸. Extended-release should not be chewed or crushed to maintain the release mechanism⁵. Choose extended-release for once-daily dosing convenience in ADHD; immediate-release for flexible hypertension dosing¹⁴.

Dosage and Administration

For ADHD in children 6 years and older, start with 1 mg extended-release once daily (morning or evening), titrating weekly by 1 mg increments to a maximum of 4 mg/day based on response and tolerance²⁵. For hypertension, dosages vary; immediate-release is typically 1-3 mg/day in divided doses². Administer consistently at the same time daily; do not abruptly stop, as it may cause rebound hypertension⁴. Take with or without food, but avoid crushing extended-release tablets⁵. Full ADHD benefits may take 4-8 weeks⁶. Use in children under 6 requires physician determination². Monitor blood pressure and heart rate during titration¹.

Scientific Research and Mechanism of Action

Guanfacine selectively activates alpha-2A adrenergic receptors in the prefrontal cortex, inhibiting cAMP-mediated channel opening, which strengthens synaptic connectivity, enhances neuronal firing, and improves working memory, attention, and impulse control¹. This reduces sympathetic outflow, lowering blood pressure by relaxing vessels². Studies in monkeys show benefits independent of sedation¹. Clinical trials demonstrate 1-4 mg/day extended-release reduces ADHD Rating Scale scores by 17-21 points vs. 9-12 for placebo over 8-9 weeks⁵. Effective as monotherapy or adjunct to stimulants for ADHD in ages 6-17⁶⁷. Research from Yale"s Arnsten Lab supports prefrontal disorder treatment¹. It also aids PTSD hyperarousal via prolonged half-life and nightmare reduction¹. Current evidence supports short-term efficacy; long-term data ongoing⁵.

Benefits and Potential Uses

Guanfacine effectively treats ADHD by improving attention, reducing hyperactivity, impulsivity, and restlessness, especially in children 6-17, either alone or with stimulants²⁵⁶. For hypertension, it lowers systolic and diastolic pressure, reducing risks of stroke, heart failure, and kidney damage². Potential uses include tics, PTSD symptoms (hyperarousal, nightmares, impulsivity), and trauma-related issues in children¹⁴. Non-stimulant nature makes it suitable for stimulant-intolerant patients or those with tics⁵. Short-term trials show significant symptom reduction; benefits peak in 4-8 weeks⁶. It supports overall ADHD management with psychological and educational interventions².

Side Effects and Risks

Common side effects include sleepiness (somnolence), fatigue, dry mouth, constipation, and low blood pressure¹⁵. Sedation affects 9-40% initially, often improving after 2-3 weeks; 12% discontinue due to it⁵. Other risks: urinary issues, dizziness, headache¹. Abrupt discontinuation may cause rebound hypertension⁴. Use caution in heart disease, low BP, or kidney/liver impairment¹. Not recommended under 6 without supervision; monitor growth in children². Rare severe sedation possible⁵.

Interactions and Precautions

Guanfacine interacts with CNS depressants (e.g., alcohol, sedatives) amplifying sedation; avoid with strong CYP3A4 inhibitors (e.g., ketoconazole) increasing levels¹³. May enhance antihypertensives" BP-lowering; caution with beta-blockers². Precautions for elderly (higher sedation risk), pregnant/breastfeeding (limited data), and those with bradycardia or hypotension¹. Taper dose before surgery to avoid BP fluctuations². Monitor in heart conditions; not for acute hypotension¹. Inform doctor of all meds³.

Impact on Biomarkers

Guanfacine lowers systolic and diastolic blood pressure and heart rate via sympathetic inhibition¹². Monitor BP and pulse regularly, especially during titration or discontinuation⁵. May affect liver enzymes (CYP3A4 substrate); check in polypharmacy³. No major impacts on glucose, lipids, or inflammatory markers noted¹.

Overdose and Toxicity

Overdose risks severe hypotension, bradycardia, sedation, respiratory depression; seek emergency care¹. Toxicity symptoms: extreme drowsiness, slow heart rate, fainting². No established safe upper limit beyond 4 mg/day ADHD max; titrate carefully⁵. Management: activated charcoal, IV fluids, vasopressors if needed¹.

Disclaimer

The information provided in this document is for educational purposes only and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.